Paper24314899
Ondansetron and the risk of cardiac arrhythmias: a systematic review and postmarketing analysis.
Freedman SB and 3 others. Ann Emerg Med, 2014. Cited by 93 papers, by iCite.
Cite this record
ConductScience Library. Ondansetron and the risk of cardiac arrhythmias: a systematic review and postmarketing analysis. Papers, record 24314899. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24314899
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Ondansetron and the risk of cardiac arrhythmias: a systematic review and postmarketing analysis.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antiemetics | Major topic |
| Arrhythmias, Cardiac | Major topic |
| Ondansetron | Major topic |
| Product Surveillance, Postmarketing | Major topic |
| Emergency Treatment | |
| Humans | |
| Monitoring, Physiologic | |
| Risk |
Source PubMed
Cited by42
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 93 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42818164 | A Computational Model of Oxidative Stress in a Human Ventricular Myocyte. | bioRxiv | 2026 | https://conductscience.org/library/papers/42818164 | PubMed |
| 42748473 | Antiemetic-associated QT prolongation: a clinical review and risk-stratified prescribing framework for long QT syndrome. | Eur Heart J Cardiovasc Pharmacother | 2026 | https://conductscience.org/library/papers/42748473 | PubMed |
| 42473072 | Oral food challenges in FPIES: A narrative review and proposals for emergency and home-based management of acute FPIES reaction. | Pediatr Allergy Immunol | 2026 | https://conductscience.org/library/papers/42473072 | PubMed |
| 41800097 | QT-related adverse events with ondansetron and olanzapine: a real-world FAERS analysis with implications for oncology anti-emetic practice. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/41800097 | PubMed |
| 41472511 | Major Adverse Cardiac Events with Ondansetron: A Systematic Review. | Clin Pharmacol Ther | 2026 | https://conductscience.org/library/papers/41472511 | PubMed |
| 41408751 | Arrhythmia risk predictions from molecular simulations of cardiac ion channel-drug interactions. | Biophys J | 2026 | https://conductscience.org/library/papers/41408751 | PubMed |
| 41293240 | The correlation between the use of ondansetron and mortality in sepsis associated encephalopathy patients: a retrospective ICU cohort study. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41293240 | PubMed |
| 41210447 | Ondansetron-induced cardiac arrest and cardiomyopathy with successful reversal: a case report. | AME Case Rep | 2025 | https://conductscience.org/library/papers/41210447 | PubMed |
| 41040275 | Prediction of TdP Arrhythmia Risk Through Molecular Simulations of Conformation-specific Drug Interactions with the hERG K+, Nav1.5, and Cav1.2 Channels. | bioRxiv | 2025 | https://conductscience.org/library/papers/41040275 | PubMed |
| 40856942 | Morbidity and Mortality of Ondansetron in Patients with Non-congenital Long QT Syndrome: A Review Article. | Cardiovasc Drugs Ther | 2026 | https://conductscience.org/library/papers/40856942 | PubMed |
| 40725767 | Inhaling Peppermint Essential Oil as a Promising Complementary Therapy in the Treatment of Nausea and Vomiting. | J Clin Med | 2025 | https://conductscience.org/library/papers/40725767 | PubMed |
| 38882995 | Prevalence, Attributes, and Risk Factors of QT-Interval-Prolonging Drugs and Potential Drug-Drug Interactions in Cancer Patients: A Prospective Study in a Tertiary Care Hospital. | Cureus | 2024 | https://conductscience.org/library/papers/38882995 | PubMed |
| 38566008 | Single intravenous dose ondansetron induces QT prolongation in adult emergency department patients: a prospective observational study. | Int J Emerg Med | 2024 | https://conductscience.org/library/papers/38566008 | PubMed |
| 38380631 | Understanding Australian Pharmacists' Perceptions on the Utilisation of Oral 5-HT3 Antagonists as Pharmacist-Only Anti-Emetics in Comparison to Oral D2 Antagonists. | J Pharm Pract | 2024 | https://conductscience.org/library/papers/38380631 | PubMed |
| 38179420 | Effects of ondansetron exposure during ICU stay on outcomes of critically ill patients with sepsis: a cohort study. | Front Cell Infect Microbiol | 2023 | https://conductscience.org/library/papers/38179420 | PubMed |
| 37936910 | Efficacy and safety of ondansetron for morning sickness in pregnancy: a systematic review of clinical trials. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/37936910 | PubMed |
| 37680391 | Evaluation of cardiac indices using M-mode echocardiography after administration of metoclopramide and ondansetron in donkeys (Equus asinus): an experimental study. | Front Vet Sci | 2023 | https://conductscience.org/library/papers/37680391 | PubMed |
| 36110896 | Management of Chronic Migraine in Children and Adolescents: Where are We in 2022? | Pediatric Health Med Ther | 2022 | https://conductscience.org/library/papers/36110896 | PubMed |
| 35784927 | Early Postoperative Ondansetron Exposure is Associated with Reduced 90-Day Mortality in Patients Undergoing Cardiac Surgery. | Front Surg | 2022 | https://conductscience.org/library/papers/35784927 | PubMed |
| 35666723 | Clinical practice guideline of the Interamerican Society of Cardiology on primary prevention of cardiovascular disease in women. | Arch Cardiol Mex | 2022 | https://conductscience.org/library/papers/35666723 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24314899
GET https://conductscience.org/api/papers/v1/24314899/cited_by?page=2